Larry Danziger, Pharm.D

Co-Chair and Moderator

Larry Danziger, Pharm.D
Professor, Department of Pharmacy Practice
Co-Director, Section of Infectious Diseases Pharmacotherapy
Colleges of Pharmacy and Medicine
University of Illinois at Chicago

Larry Danziger, Pharm.D. is a Professor of Pharmacy and Medicine at UIC and Co-Director of the Section of Infectious Diseases, Department of Pharmacy Practice, and also the Executive Director of the Center for Advanced Design, Research and Exploration (CADRE). Dr. Danziger has been on faculty at UIC for 35 years. Dr. Danziger’s research interests include basic and clinical research regarding both new and old antimicrobials. Dr. Danziger is an elected member of the Society of Infectious Disease Pharmacists, the Infectious Disease Society of America, and the Surgical Infection Society.  He is also a member of the American College of Clinical Pharmacy, the American Society for Microbiology, and the American Society of Health System Pharmacists.

Dr. Danziger has authored or coauthored over 150 journal articles, 150 research abstracts and 22 book chapters.  He is on the editorial board of the journal Diagnostic Microbiology and Infectious Diseases and Antibiotics.

Dr. Danziger’s research interests include basic and clinical research regarding both new and old antimicrobials. He played a critical role in the redevelopment of paromomycin, an antibiotic originally developed in the 1950s, in collaboration with the University of Illinois at Chicago and the WHO.

Keith A. Rodvold, Pharm.D., FCCP, FIDSA

Co-Chair and Speaker

Keith A. Rodvold, Pharm.D., FCCP, FIDSA
UIC Distinguished Professor
Co-Director, Section of Infectious Diseases Pharmacotherapy
Colleges of Pharmacy and Medicine
University of Illinois at Chicago

Dr. Keith A. Rodvold received his Bachelor of Science in pharmacy (1978) and Doctor of Pharmacy (1980) degrees from the University of Minnesota. He completed his research fellowship in clinical pharmacokinetics and pharmacology at St. Paul-Ramsey Medical Center and the University of Minnesota (1980-1981) and was a Clinical Pharmacy Specialist at St. Joseph’s Hospital in Marshfield, Wisconsin, from 1981 to 1984.  Dr. Rodvold was appointed as an Assistant Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago (UIC) in 1984, was promoted to the rank of Associate Professor with tenure in 1989, and to the rank of Professor in 1994.  In 2020, Dr. Rodvold was appointed the title of UIC Distinguished Professor. He is also a Professor of Pharmacy in Medicine in the College of Medicine at UIC. Dr. Rodvold is currently conducting research in the area of clinical pharmacokinetics and pharmacodynamics of anti-infective agents for infectious diseases.  Dr. Rodvold has authored more than 200 original research and review publications, 60 book chapters, and has edited 6 textbooks.  The American College of Clinical Pharmacy presented Dr. Rodvold with the 2003 Russell R. Miller Award in recognition of his sustained and outstanding contributions to the literature of clinical pharmacy. Dr. Rodvold is a former member of the Anti-Infective Drug Advisory Committee and Pediatric Drug Advisory Subcommittee for the United States Food and Drug Administration.  He is an active member of numerous professional societies and has been elected Fellow of the Infectious Diseases Society of America, American College of Clinical Pharmacology, and American College of Clinical Pharmacy.

Marin H. Kollef, MD, FACP, FCCP

Marin H. Kollef, MD, FACP, FCCP
Professor, Medicine
Division of Pulmonary and Critical Care Medicine
Washington University

Dr. Marin Kollef is a Professor of Medicine at Washington University School of Medicine, holds the Virginia E. and Sam J. Golman Chair in Respiratory Intensive Care Medicine, and is Director of Respiratory Care Services and Director of Critical Care Research at Barnes-Jewish Hospital in St. Louis, Missouri. Dr. Kollef attended the U.S. Military Academy at West Point for his undergraduate training and the University of Rochester for his M.D. degree. Dr. Kollef completed his residency in Internal Medicine and his fellowship in Pulmonary and Critical Care Medicine at Madigan Army Medical Center in Tacoma, Washington. He served as the director for the medical ICU at Fitzsimons Army Medical Center from 1988 to 1992. During that time he also served as a general medical officer in support of the 1st Infantry Division during Operation Desert Storm. He joined Washington University School of Medicine and Barnes-Jewish Hospital in 1992.

Dr. Kollef is the recipient of numerous honors and awards including selection to “Best Doctors in America,” Central Region and Barnes-Jewish Hospital Team Awards for Quality Improvement for programs directed to VAP prevention, bloodstream infection prevention, and the “Surviving Sepsis Initiative.” His awards for military service with the First Infantry Division (Mechanized) during Operation Desert Storm include the Bronze Star, Meritorious Service Medal, and Combat Medical Badge in Support of Combat Operations. He is also a member of the American Thoracic Society, Society of Critical Care   Medicine, American Association for Respiratory Care, and American Society of Clinical Investigation. He is a member of the CDC/OID/NPC DCID Defining Surveillance Definitions for VAP and the Chair for Global Anti-Infectives Leadership Academy.

Dr. Kollef currently serves on the editorial boards of Respiratory Care, Critical Care– the Official Journal of the Critical Care Forum, Critical Care Medicine, Informed Decisions/Clinical Strategies, and the Journal of Surgical Infections. He is a fellow of the American College of Physicians and the American College of Chest Physicians.

Manjunath (Amit) P. Pai, PharmD, FCP

Manjunath (Amit) P. Pai, PharmD, FCP
Professor and Chair, Department of Clinical Pharmacy
Deputy Director of the PK Core
College of Pharmacy
University of Michigan

Dr. Pai’s is Professor and Chair of Clinical Pharmacy at the University of Michigan, College of Pharmacy with a research focus in optimal drug dose selection in underrepresented specific populations. He earned his Pharm.D. from the University of Texas Health Sciences Center in San Antonio, Texas. He completed a pharmacy practice residency at Bassett Healthcare in Cooperstown, New York, and an Infectious Diseases fellowship at the University of Illinois at Chicago. Dr. Pai’s research focus is precision pharmacotherapy in specific populations like abnormal kidney function and obesity.

Andrew Shorr, MD, MPH, MBA

Andrew Shorr, MD, MPH, MBA
Section Head of Pulmonary and Critical Care Medicine
MedStar Washington Hospital Center
Professor of Medicine
Georgetown University

Disclosures

Dr. Danziger is a speaker for Paratek Pharma and Shionogi. Dr. Kollef is a consultant for Merck, Pfizer, and Shionogi. Dr. Pai is a consultant for Paratek Pharma and Wolters-Kluwer and has received research support from Merck.  Dr. Rodvold is a speaker for Merck and Shionogi and is a consultant for the Medicine Company and VenatoRx. Dr. Shorr is a speaker for Merck and is a consultant for Entasis, Merck, Pfizer, Shionogi, and Spero. Dr. Novak, CME Faculty Advisor, is a consultant for Viiv Pharmaceuticals and a principle investigator for Janssen. All other planning committee members who contributed to the activity have no relevant financial conflicts of interest to disclose.